Received Mar 10, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | 34mf9 | — |
| DTAPIPV | DTAP + IPV (KINRIX) | GLAXOSMITHKLINE BIOLOGICALS | 1 | UNK | — |
received their first dose of KINRIX when they were 7 years old; nurse accidentally administered KINRIX today to a patient instead of Boostrix; Extra dose administered; This non-serious case was reported by a nurse via call center representative and described the occurrence of wrong vaccine administered in a 11-year-old female patient who received DTPa-IPV (Kinrix) (batch number 34mf9, expiry date 13-FEB-2026) for prophylaxis. Co-suspect products included DTPa (Reduced antigen) (Boostrix) for prophylaxis and DTPa-IPV (Kinrix) for prophylaxis. On 28-FEB-2025, the patient received the 2nd dose of Kinrix. On an unknown date, the patient received Boostrix and the 1st dose of Kinrix. On 28-FEB-2025, immediately after receiving Kinrix and not applicable after receiving Boostrix and Kinrix, the patient experienced wrong vaccine administered (Verbatim: nurse accidentally administered KINRIX today to a patient instead of Boostrix) and extra dose administered (Verbatim: Extra dose administered). On an unknown date, the patient experienced inappropriate age at vaccine administration (Verbatim: received their first dose of KINRIX when they were 7 years old). The outcome of the wrong vaccine administered, extra dose administered and inappropriate age at vaccine administration were not applicable. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date:28-FEB-2025 The another nurse accidentally administered Kinrix at the time of reporting to a patient instead of Boostrix , which led to wrong vaccine administered and extra dose administered. The patient received their first dose of Kinrix when they were 7 years old, which led to inappropriate age at vaccine administration This case was two of the three cases reported by the same reporter for different patient.; Sender's Comments: US-GSK-US2025025491:same reporter US-GSK-US2025025487:same reporter